Pharmaceutical

Construction begins on MSD’s $1bn biologics centre in Delaware, US

MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.

Apr 30, 2025 - 06:00
Construction begins on MSD’s $1bn biologics centre in Delaware, US
MSD has begun construction on a $1bn biologics centre of excellence, Merck Wilmington Biotech, in the US state of Delaware.
Read the original article

Tags:

Previous Article

Impending US tariffs signal uncertain future for global pharma, says GlobalData

Next Article

US tariffs likely to disrupt drug development costs and prices, says GlobalData

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Change Healthcare cyberattack outage could persist for weeks, UnitedHealth Group executive suggests

STAT+: Change Healthcare cyberattack outage could persi...

Feb 29, 2024

Verix boosts life science AI capabilities with start-up.ai acquisition

Verix boosts life science AI capabilities with start-up...

Jun 17, 2023

The evolving presence of AI in telemedicine for behavioural health

The evolving presence of AI in telemedicine for behavio...

Jan 17, 2024